Clinical Trials Logo

Clinical Trial Summary

This double-blinded, randomized, placebo-controlled study aimed to evaluate the efficacy and safety of AP collagen peptides (APCP) containing 3% Glycine-Proline-Hydroxyproline (GPH) on improving skin health. Subjects with dried skin were randomly assigned to receive placebo or APCP once daily for 12 weeks.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05059197
Study type Interventional
Source Amorepacific Corporation
Status Active, not recruiting
Phase N/A
Start date December 15, 2020
Completion date December 15, 2021

See also
  Status Clinical Trial Phase
Completed NCT03824886 - Enhancing SKIN Health and Safety in Aged CARE N/A
Active, not recruiting NCT05013645 - Evaluation of Skin Hydration in Adults With Dry Skin Using a Moisturizer With an Added Sterilized Probiotic N/A
Completed NCT04085809 - This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic N/A
Completed NCT03804710 - To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function N/A
Completed NCT01305057 - Efficacy Test on Skin Hydration and Skin Barrier Function N/A
Completed NCT00368563 - A Capacitance and Transepidermal Water Loss Test to Determine the Ability of Sunscreen to Moisturize Skin Phase 2/Phase 3